Enhabit, Inc. (NYSE:EHAB) Given Consensus Recommendation of “Hold” by Analysts

Posted by Stanley Muller on May 18th, 2026

Shares of Enhabit, Inc. (NYSE:EHAB – Get Free Report) have received an average rating of “Hold” from the nine brokerages that are currently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the company. The average 1-year price target among brokerages that have updated their coverage on the stock in the last year is $13.5714.

EHAB has been the subject of a number of research analyst reports. Weiss Ratings reissued a “sell (d-)” rating on shares of Enhabit in a research report on Tuesday, April 14th. Truist Financial set a $13.80 price target on shares of Enhabit in a research report on Monday, February 23rd. UBS Group reaffirmed a “neutral” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Oppenheimer cut shares of Enhabit from an “outperform” rating to a “market perform” rating in a research report on Monday, February 23rd. Finally, Leerink Partners upped their price target on shares of Enhabit from $9.50 to $13.80 and gave the stock a “market perform” rating in a research report on Monday, February 23rd.

Read Our Latest Stock Report on Enhabit

Insider Buying and Selling

In related news, EVP Julie Diane Jolley sold 2,793 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $13.63, for a total transaction of $38,068.59. Following the transaction, the executive vice president directly owned 139,923 shares of the company’s stock, valued at approximately $1,907,150.49. The trade was a 1.96% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Company insiders own 3.40% of the company’s stock.

Hedge Funds Weigh In On Enhabit

Several hedge funds and other institutional investors have recently bought and sold shares of EHAB. Polar Asset Management Partners Inc. purchased a new stake in Enhabit during the 1st quarter worth $1,409,000. Lazard Asset Management LLC grew its stake in Enhabit by 35.5% during the 1st quarter. Lazard Asset Management LLC now owns 481,889 shares of the company’s stock valued at $6,790,000 after purchasing an additional 126,319 shares in the last quarter. OMERS ADMINISTRATION Corp acquired a new stake in Enhabit during the 1st quarter valued at approximately $1,770,000. Renaissance Technologies LLC grew its stake in Enhabit by 115.4% during the 1st quarter. Renaissance Technologies LLC now owns 787,768 shares of the company’s stock valued at $11,100,000 after purchasing an additional 421,968 shares in the last quarter. Finally, Gabelli Funds LLC bought a new position in Enhabit during the 1st quarter valued at $5,074,000.

Enhabit Stock Performance

Shares of EHAB opened at $13.80 on Monday. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $706.97 million, a P/E ratio of -153.33 and a beta of 1.26. The stock’s fifty day simple moving average is $13.77 and its 200 day simple moving average is $11.32. Enhabit has a twelve month low of $6.47 and a twelve month high of $14.22.

Enhabit (NYSE:EHAB – Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported $0.36 earnings per share (EPS) for the quarter. The firm had revenue of $264.80 million during the quarter. Enhabit had a negative net margin of 0.30% and a positive return on equity of 7.24%. On average, equities research analysts forecast that Enhabit will post 0.58 earnings per share for the current year.

Enhabit Company Profile

(Get Free Report)

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.

Analyst Recommendations for Enhabit (NYSE:EHAB)

Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.